T
TAKEDA PHARMACEUTICAL CO LTD
TAKEDA PHARMACEUTICAL CO LTD is an institution, managing $16.4M across 8 long positions as of Q3 2025 with 100% Healthcare concentration, with only 8 positions, and 60% allocation to OVID.
- Portfolio Value
- $16.4M
- Positions
- 8
- Top Holding
- OVID at 59.82%
- Last Reported
- Q3 2025
Top Holdings
Largest long holdings in TAKEDA PHARMACEUTICAL CO LTD's portfolio (100% of total portfolio)
GthenH
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $9.8M | 59.82% | — | 10.59% 7.5M shares | |
Biotechnology Healthcare | $2.6M | 15.94% | — | 3.07% 1.8M shares | |
Biotechnology Healthcare | $1.2M | 7.59% | — | 2.85% 1.5M shares | |
Biotechnology Healthcare | $1.2M | 7.53% | — | 1.08% 515.6K shares | |
Biotechnology Healthcare | $891.4K | 5.45% | +$222.8K Bought | 0.29% 54.9K shares | |
Medical - Healthcare Information Services Healthcare | $478.1K | 2.92% | — | 0.48% 77.7K shares | |
Biotechnology Healthcare | $101.6K | 0.62% | — | 0.42% 203.2K shares | |
Medical - Diagnostics & Research Healthcare | $21.5K | 0.13% | — | 0.00% 16.5K shares |
Changes
Portfolio activity, position movements, and quarter-over-quarter changes in TAKEDA PHARMACEUTICAL CO LTD's latest filing
GthenC
Market Value
Q/Q Change
Net Flows % of MV
Turnover Ratio
New Purchases
Added To
Sold Out Of
Reduced Holdings
Increased Positions
| Position | Shares Δ |
|---|---|
+33.33% |
Decreased Positions
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
Sold |
Analytics
Portfolio insights and performance metrics for TAKEDA PHARMACEUTICAL CO LTD
GthenA